Cargando…
AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model
AXL tyrosine kinase activation enhances cancer cell survival, migration, invasiveness, and promotes drug resistance. AXL overexpression is typically detected in a high percentage of renal cell carcinomas (RCCs) and is strongly associated with poor prognosis. Therefore, AXL inhibition represents an a...
Autores principales: | Chen, Tony J., Mydel, Piotr, Benedyk‐Machaczka, Małgorzata, Kamińska, Marta, Kalucka, Urszula, Blø, Magnus, Furriol, Jessica, Gausdal, Gro, Lorens, James, Osman, Tarig, Marti, Hans‐Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652404/ https://www.ncbi.nlm.nih.gov/pubmed/34877810 http://dx.doi.org/10.14814/phy2.15140 |
Ejemplares similares
-
Axl‐inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model
por: Hoel, August, et al.
Publicado: (2021) -
AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction
por: Landolt, Lea, et al.
Publicado: (2019) -
Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor
por: Aliko, Ardita, et al.
Publicado: (2019) -
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
por: Tutusaus, Anna, et al.
Publicado: (2019) -
Enhanced gene expression from retroviral vectors
por: Blø, Magnus, et al.
Publicado: (2008)